Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Pathogens 2013, 2(1), 33-54; doi:10.3390/pathogens2010033
Review

Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance

1
, 2,3
 and 2,3,*
Received: 8 December 2012; in revised form: 18 January 2013 / Accepted: 23 January 2013 / Published: 4 February 2013
(This article belongs to the Special Issue Host-Parasite Interactions)
View Full-Text   |   Download PDF [623 KB, uploaded 4 February 2013]   |   Browse Figures
Abstract: Malaria continues to exact a great human toll in tropical settings. Antimalarial resistance is rife and the parasite inexorably develops mechanisms to outwit our best drugs, including the now first-line choice, artesunate. Novel strategies to circumvent resistance are needed. Here we detail drug development focusing on heat shock protein 90 and its central role as a chaperone. A growing body of evidence supports the role for Hsp90 inhibitors as adjunctive drugs able to restore susceptibility to traditionally efficacious compounds like chloroquine.
Keywords: malaria; hsp90; antimalarial resistance malaria; hsp90; antimalarial resistance
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Shahinas, D.; Folefoc, A.; Pillai, D.R. Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance. Pathogens 2013, 2, 33-54.

AMA Style

Shahinas D, Folefoc A, Pillai DR. Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance. Pathogens. 2013; 2(1):33-54.

Chicago/Turabian Style

Shahinas, Dea; Folefoc, Asongna; Pillai, Dylan R. 2013. "Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance." Pathogens 2, no. 1: 33-54.



Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert